Skip to main navigation
  • Careers
  • Contact Us
Exelixis
  • Our Story
    • Mission
    • Leadership
    • Board of Directors
    • Collaborations
  • Medicines
    • Our Medicines
    • Access
  • Research & Development
    • Research and Development
    • Pipeline
      • Pipeline Overview
      • Early-Stage Compounds
      • Cabozantinib Pipeline
      • Other Partnered Programs
    • Clinical Trials
  • Impact
    • Stories
    • Grants & Giving
    • Corporate Values & Sustainability
  • Investors & Media
    • Investors Overview
    • News and Events
      • Press Releases
      • Event Calendar
      • Media Resources
    • Stock Information
      • Stock Quote & Chart
      • Historical Price Lookup
      • Investment Calculator
      • Analyst Coverage
      • Earnings Estimates
    • Financial Information
      • Annual Reports
      • SEC Filings
      • Interactive Analyst Center
    • Investor Resources
      • Investor FAQs
      • Corporate Values & Sustainability
      • Information Request
    • Corporate Governance
      • Corporate Governance Documents and Information
      • Leadership
      • Board of Directors
      • Committee Composition and Charters
    • Contact IR
Select Page

Investors & Media

Biography

<< Back

Carl B. Feldbaum, Esq.

Director
Carl Feldbaum, Esq.
  • Member of the Nominating and Corporate Governance
  • Chair of the Risk Committee

Investor Relations

  • Investors Overview
  • News & Events
    • Press Releases
    • Event Calendar
    • Media Resources
  • Stock Information
    • Stock Quote & Chart
    • Historical Price Lookup
    • Investment Calculator
    • Analyst Coverage
    • Earnings Estimates
  • Financial Information
    • Annual Reports
    • SEC Filings
    • Interactive Analyst Center
  • Investor Resources
    • Investor FAQs
    • Corporate Values & Sustainability
    • Information Request
  • Corporate Governance
    • Corporate Governance Documents and Information
    • Leadership
    • Board of Directors
    • Committee Composition and Charters
  • Contact IR

Receive Email Alerts

Sign up to receive email alerts whenever Exelixis, Inc. posts new information to the site. Just enter your email address and click Sign Up.
Required fields denoted by an asterisk ().
Alert type

Shareholder Tools

  • Information Request
  • Print Page
  • Email Alerts
  • RSS
Tweets by ExelixisInc

Our Story

  • Mission
  • Leadership
  • Board of Directors
  • Collaborations

Medicines

  • Our Medicines
  • Access

Research & Development

  • Research & Development
  • Pipeline
  • Clinical Trials

Impact

  • Stories
  • Grants & Giving
  • Corporate Values & Sustainability

Investors & Media

    Investors & Media

    • Investors Overview
    • News & Events
    • Stock Information
    • Financial Information
    • Investor Resources
    • Corporate Governance
    • Contact IR
  • Facebook
  • Twitter
© Exelixis, Inc. 2023
  • Ethics & Compliance
  •  Privacy
  •  Terms of Use

This website uses cookies to improve and personalize content and for tracking and analytics. You can learn more from our Privacy Statement.

OK